Evidence map›Paper›PMID 25915504›Full record

ArticleLangmuir : the ACS journal of surfaces and colloids2015

Analysis of exosome release as a cellular response to MAPK pathway inhibition.

K Agarwal, M Saji, S M Lazaroff, A F Palmer, M D Ringel, M E Paulaitis

Open access · greenAbstract read
In one paragraph

Article in Langmuir : the ACS journal of surfaces and colloids, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Extracellular Vesicles for Disease Treatment.International journal of nanomedicine · 2025
    Review
  7. CRABP1-complexes in exosome secretion.Cell communication and signaling : CCS · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. A Review of Extracellular Vesicles in COVID-19 Diagnosis, Treatment, and Prevention.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  14. Article
  15. Biodistribution of therapeutic extracellular vesicles.Extracellular vesicles and circulating nucleic acids · 2023
    Review
  16. Article
  17. Review
  18. Review
  19. Realistic biomarkers from plasma extracellular vesicles for detection of beryllium exposure.International archives of occupational and environmental health · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

K AgarwalWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, Department of Chemistry, Nanoscale Science and Engineering Center for Affordable Nanoenginering of Polymeric Biomedical Devices, Department of Internal Medicine, Division of Endocrinology Diabetes and Metabolism, Arthur G. James Comprehensive Cancer Center and Richard G. Solove Research Institute, The Ohio State University, Columbus, Ohio 43210, United States.
M SajiWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, Department of Chemistry, Nanoscale Science and Engineering Center for Affordable Nanoenginering of Polymeric Biomedical Devices, Department of Internal Medicine, Division of Endocrinology Diabetes and Metabolism, Arthur G. James Comprehensive Cancer Center and Richard G. Solove Research Institute, The Ohio State University, Columbus, Ohio 43210, United States.
S M LazaroffWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, Department of Chemistry, Nanoscale Science and Engineering Center for Affordable Nanoenginering of Polymeric Biomedical Devices, Department of Internal Medicine, Division of Endocrinology Diabetes and Metabolism, Arthur G. James Comprehensive Cancer Center and Richard G. Solove Research Institute, The Ohio State University, Columbus, Ohio 43210, United States.
A F PalmerWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, Department of Chemistry, Nanoscale Science and Engineering Center for Affordable Nanoenginering of Polymeric Biomedical Devices, Department of Internal Medicine, Division of Endocrinology Diabetes and Metabolism, Arthur G. James Comprehensive Cancer Center and Richard G. Solove Research Institute, The Ohio State University, Columbus, Ohio 43210, United States.
M D RingelWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, Department of Chemistry, Nanoscale Science and Engineering Center for Affordable Nanoenginering of Polymeric Biomedical Devices, Department of Internal Medicine, Division of Endocrinology Diabetes and Metabolism, Arthur G. James Comprehensive Cancer Center and Richard G. Solove Research Institute, The Ohio State University, Columbus, Ohio 43210, United States.
M E PaulaitisWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, Department of Chemistry, Nanoscale Science and Engineering Center for Affordable Nanoenginering of Polymeric Biomedical Devices, Department of Internal Medicine, Division of Endocrinology Diabetes and Metabolism, Arthur G. James Comprehensive Cancer Center and Richard G. Solove Research Institute, The Ohio State University, Columbus, Ohio 43210, United States.
The Ohio State University · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Selective Modulation of Thyroidal RadioiodineP01CA124570 · NCI · OHIO STATE UNIVERSITY · PI RINGEL, MATTHEW D · 2008 to 2017
$23.4M
Targeted delivery of microRNA-loaded microvesicle for cancer therapyUH2TR000914 · NCATS · UNIVERSITY OF FLORIDA · PI PHELPS, MITCH A, SCHMITTGEN, THOMAS D. · 2013 to 2015
$1.5M
CellTrap: A novel solid phase platform for analysis of stem/progenitor cellsRC2AG036559 · NIA · OHIO STATE UNIVERSITY · PI COOPER, STUART L, MOLDOVAN, NICANOR I. · 2009 to 2010
$1.3M
NCATS NIH HHS UH2 TR000914NCI NIH HHS P01 CA124570NCI NIH HHS P30 CA016058NIA NIH HHS 1RC2AG036559-01NIA NIH HHS RC2 AG036559
6 · The paper itself

Abstract

Exosome size distributions and numbers of exosomes released per cell are measured by asymmetric flow-field flow fractionation/multi-angle light scattering (A4F/MALS) for three thyroid cancer cell lines as a function of a treatment that inhibits MAPK signaling pathways in the cells. We show that these cell lines release exosomes with well-defined morphological features and size distributions that reflect a common biological process for their formation and release into the extracellular environment. We find that those cell lines with constitutive activation of the MAPK signaling pathway display MEK-dependent exosome release characterized by increased numbers of exosomes released per cell. Analysis of the measured exosome size distributions based on a generalized extreme value distribution model for exosome formation in intracellular multivesicular bodies highlights the importance of this experimental observable for delineating different mechanisms of vesicle formation and predicting how changes in exosome release can be modified by pathway inhibitors in a cell context-dependent manner.

Indexed as

ExosomesFractionation, Field FlowHumansMAP Kinase Kinase KinasesMAP Kinase Signaling SystemScattering, RadiationTumor Cells, CulturedMAP Kinase Kinase Kinases

Identifiers

PMID25915504
PMCPMC4589192
OpenAlexW2041275674

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.